Followers | 4 |
Posts | 863 |
Boards Moderated | 0 |
Alias Born | 02/10/2016 |
Thursday, January 12, 2017 6:11:55 PM
Do you have evidence that the company solicited for the promissory notes by email?
You say if I did my research then I would know they are made available to the public, well perhaps I am not that good at research since I can't find the proof. I would be happy to be corrected by you if you would be willing to post the proof.
Here is what you said before:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=100965660
According to the filings only these three entities ever acquired over 5% shares (not just Boden):
Bountiful (Boden)
Cumorah (Beifuss)
Pearl (Lei)
All of these people invest in the same companies as each other, and all of the companies are scammy companies from Santa Barbara:
http://yahoo.brand.edgar-online.com/PeopleFilingResults.aspx?PersonID=3165159&PersonName=WILLIAM%20E%20BEIFUSShttp://yahoo.brand.edgar-online.com/PeopleFilingResults.aspx?PersonID=3165159&PersonName=WILLIAM%20E%20BEIFUSS
http://yahoo.brand.edgar-online.com/PeopleFilingResults.aspx?PersonID=5049458&PersonName=GREG%20BODEN
http://yahoo.brand.edgar-online.com/PeopleFilingResults.aspx?PersonID=4442806&PersonName=ELAINE%20LEI
All of these people can be connected pretty easily back to Nelson. Nelson himself has even claimed to be friends with Beifuss, the largest holder.
Anybody who owned a good chunk of any of those p-notes back then would have been over 5% and forced to file, yet it never happened.
So it's appropriate to raise concerns when the CEO's friends and associates are getting extremely rich off the stock, while ordinary holders are not. The reason they are rich is not because they invested early, but because they were given millions of shares at $0.338 a share when the stock was trading at $3.00 a share for normal investors.
Even those discounted warrants were well above that price, they literally could not lose, and normal shareholders were screwed over by their own CEO.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM